Analysts' Actions: Allergan, Amazon, Five Below, Hasbro, Sanmina


Allergan (AGN) was upgraded at UBS to buy from neutral. Twelve-month price target is $200. The company plans to see more sales growth while it considers a deal with Valeant (VRX). (AMZN) was downgraded to neutral at Citigroup. Twelve-month price target is $395. Company lacks transparency, and management continues to invest heavily in the business, Citigroup said.

American Axle (AXL) was upgraded at J.P. Morgan to neutral from underweight. Estimates were also increased, given recent production trends, J.P. Morgan said.

Herb Greenberg: Allergan's Dilemma

The End of Quantitative Easing and What It Means for Commodities

JetBlue, With Expectations Low, Could Face Changes

Amcon Distributing (DIT) was upgraded to buy at TheStreet Ratings.

Evolving Systems (EVOL) was upgraded to buy at TheStreet Ratings.

Five Below (FIVE) was upgraded at Wells Fargo to outperform. Company's growth opportunity is increasing and management continues to execute, Wells Fargo said.

Hasbro (HAS) was upgraded at Barclays to overweight from equal weight. Drivers include strong POS trends, strength of boys revenue growth, and growth in girls segment, Barclays said. Twelve-month price target is $59.

Matador Resources (MTDR) was downgraded at Stifel Nicolaus to hold from buy. Primarily a valuation call, Stifel Nicolaus said. Although the company's first three Permian Basin wells are clearly outperforming the average of nearby competitors, the stock appears to be reflecting most of this potential, Stifel Nicolaus said.

If you liked this article you might like

Market Recon: Jobs Day Could Turn Into a Negative Sentiment Trade

Bullish and Bearish Reversals for This Week

Analysts' Actions -- Carter's, PulteGroup, Under Armour, Zillow and More

Market Recon: 'Phenomenal' Tax Cuts Promise Lights Fire Under Market

You Asked for It: My List of 9 Leveraged Small-Cap Cheapies